Creon
List of products in the National Drug Code with proprietary name creon. This medication contains digestive enzymes to help break down and digest fats, starch, and proteins in food. It is used in conditions where the pancreas cannot make or does not release enough digestive enzymes into the small intestines to digest the food (conditions such as chronic pancreatitis, cystic fibrosis, cancer of the pancreas, post-pancreatectomy, post-gastrointestinal bypass surgery).
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0032-0045 | Creon | Pancrelipase | Capsule, Delayed Release | Oral | Abbvie Inc. | Human Prescription Drug |
0032-0046 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-0047 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-1203 | Creon | Pancrelipase | Capsule, Delayed Release | Oral | Abbvie Inc. | Human Prescription Drug |
0032-1206 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-1212 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-1224 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-2636 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-2637 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
0032-3016 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | Human Prescription Drug |
17856-1206 | Creon | Atlantic Biologicals Corps | ||||
17856-1212 | Creon | Atlantic Biologicals Corps | ||||
17856-1224 | Creon | Atlantic Biologicals Corps | ||||
54868-6067 | Creon | Physicians Total Care, Inc. |